(Q40153829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Meier F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Busch S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Lasithiotakis K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kulms D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Maczey E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Herlyn M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Schittek B

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

28 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1204-1213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17388918%20AND%20SRC:MED&resulttype=core&format=json

Mutations of the BRAF gene in human cancer

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Reciprocal regulation of MelCAM and AKT in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Get a ligand, get a life: integrins, signaling and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

B-RAF is a therapeutic target in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

New techniques for the in vitro culture of human skin keratinocytes and perspectives on their use for grafting of patients with extensive burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Human melanoma progression in skin reconstructs : biological significance of bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Topical treatment with inhibitors of the phosphatidylinositol 3'-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

PED mediates AKT-dependent chemoresistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

LY294002 inhibits monocyte chemoattractant protein-1 expression through a phosphatidylinositol 3-kinase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Role of MAP kinase in tumor progression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

AKT plays a central role in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07821.X